FDA Approves First Test for Zika in Human BloodLast Updated: May 31, 2019.
THURSDAY, May 30, 2019 (HealthDay News) -- The first test to detect the Zika virus in human blood has been approved by the U.S. Food and Drug Administration.
The test is called the ZIKV Detect 2.0 IgM Capture ELISA and is made by Seattle-based InBios, which makes tests for other viruses such as West Nile and dengue, CBS News reported. Until now, the only FDA-approved tests for Zika were used to detect virus antibodies and were only for emergency use.
Zika "continues to be a problem in many parts of the world," according to the U.S. Centers for Disease Control and Prevention. There is no vaccine to prevent Zika infection or medicine to treat it.
In the United States, CDC data show that the majority of the 5,600 cases of Zika in 2016 and 2017 occurred in people who traveled to affected areas, but there were 339 mosquito-borne infections in Florida and Texas, CBS News reported.
|Previous: Financial Disaster May Prompt Self-Destructive Behavior||Next: FDA Takes Hard Look at CBD|
Reader comments on this article are listed below. Review our comments policy.